ALOPECIA [dsyn]    
Patients [podg]    
Treated [ftcn]    
molecularly targeted therapy [topp]    
ALOPECIA [dsyn]    
ADVERSE EVENT [patf]    
Targeted Therapy [topp]    
Patients [podg]    
Health [idcn]    
Related [qlco]    
Quality [qlco]    
Life [idcn]    
Targeted [ftcn]    
Agent [chvf]    
Significantly high [qnco]    
Placebo [topp]    
LOWER [spco]    
Chemotherapy [topp]    
findings [ftcn]    
decisions [menp]    
therapy [ftcn]    
Pre [tmco]    
Counselling [hlca]    
Based [ftcn]    
Management [ocac]    
strategies [menp]    
Identification [menp]    
Risk Factors [qnco]    
Introduction [hlca]    
molecularly targeted therapy [topp]    
Present [qnco]    
NEW [qlco]    
challenges [hlca]    
Dermatologic [spco]    
adverse events [patf]    
ALOPECIA [dsyn]    
Frequently [tmco]    
Reported [inpr]    
TRUE [qlco]    
Known [qlco]    
Patients [podg]    
Methods [inpr]    
ALOPECIA [dsyn]    
treatment [ftcn]    
Approved [qlco]    
inhibitors [chvf]    
oncogen [hops]    
Pathways [moft]    
Molecules [sbst]    
BREAKPOINT CLUSTER REGION [gngm]    
Rapidly [qlco]    
Accelerated [ftcn]    
FIBROSARCOMA [neop]    
human epidermal growth factor receptor 2 [gngm]    
Mammalian [mamm]    
Target [ftcn]    
CD20 [lbpr]    
Database, Electronic [inpr]    
PubMed [inpr]    
Web [mnob]    
Science [ocdi]    
ASCO [pros]    
Meeting [acty]    
Abstract [ocac]    
search [inpr]    
Conduct [inbe]    
CLINICAL TRIALS [resa]    
Reporting [hlca]    
ALOPECIA [dsyn]    
Meta-Analysis [inpr]    
Conduct [inbe]    
Fixed [qlco]    
RANDOM [resa]    
Effects [qlco]    
Models [inpr]    
Calculated [ftcn]    
Grade [clas]    
ALOPECIA [dsyn]    
14 7 [qnco]    
Lowest [qlco]    
Highest [qlco]    
Increased [qnco]    
Grade [clas]    
ALOPECIA [dsyn]    
Relative Risk [qnco]    
7 - 9 [fndg]    
Compared [acty]    
Placebo [topp]    
Compared [acty]    
Chemotherapy [topp]    
LOWER [spco]    
Relative Risk [qnco]    
Conclusions [idcn]    
Targeted Therapy [topp]    
Increased [qnco]    
ALOPECIA [dsyn]    
